CION Ameerpet
When a cancer travels to the brain, it is called a brain metastasis. Knowing the source cancer guides treatment — at CION we combine focused radiation with therapy for your primary cancer.
When a cancer that started in another organ travels to the brain, it is called a brain metastasis (a secondary brain tumour). The cancer cells still look like the original cancer under the microscope — a lung-cancer brain metastasis is made of lung-cancer cells, not brain cells. That is why the source cancer guides treatment.
Brain metastases are not rare. In fact, secondary brain tumours are several times more common than primary brain cancers that begin in the brain itself. Understanding which cancers most often spread to the brain helps patients and families know what to watch for — and how care is planned. This page explains the five cancers behind most cases, how brain spread is found, and how it is treated at CION Cancer Clinics in Hyderabad.
CION delivers the core care for brain metastases directly: contrast MRI and PET imaging, molecular testing, focused radiation (stereotactic radiosurgery and IMRT/IGRT), steroid and seizure management, and systemic therapy for the primary cancer. Any neurosurgery is coordinated with accredited neurosurgical partners.
Brain metastases are the most common type of brain tumour in adults — they occur far more often than primary brain cancers that start in the brain itself. According to the National Comprehensive Cancer Network (NCCN) Central Nervous System guidelines, lung cancer, breast cancer, and melanoma are the three cancers responsible for the majority of brain metastases. This is why any patient with an advanced cancer who develops new neurological symptoms should have a contrast MRI of the brain.
A small number of cancers account for the large majority of brain metastases. Lung and breast cancer together cause more than half of all cases. The list below explains how each one behaves — and links to detailed care for the primary cancer.
Lung cancer is the single most frequent cause of brain metastases. Both major types — non-small cell and small cell lung cancer — can reach the brain, sometimes as the first sign of the disease. Many lung cancers carry driver mutations (such as EGFR or ALK) that are tested at diagnosis, because several modern targeted drugs are designed to cross into the brain. Read more about lung cancer that has spread to the brain.
Breast cancer is the second most common source. HER2-positive and triple-negative breast cancers have a higher tendency to reach the brain. Receptor testing (ER, PR, HER2) is essential because it determines which systemic therapies — including newer brain-penetrating drugs — may control both the brain and the body. See our dedicated guide on breast cancer that has spread to the brain.
For its frequency, melanoma has one of the highest tendencies of any cancer to spread to the brain. It often produces multiple lesions. Testing for mutations such as BRAF guides treatment, and modern immunotherapy can shrink melanoma brain metastases in many patients — sometimes alongside focused radiation.
Kidney cancer can spread to the brain even years after the original diagnosis. These metastases are well suited to focused radiation, and targeted and immunotherapy drugs for advanced kidney cancer often work in tandem with brain-directed treatment.
Colon and rectal cancers spread to the brain less often than the four above, and usually later in the disease — frequently after spread to the lung or liver. When brain lesions do appear, molecular testing of the tumour (such as RAS and BRAF status) helps shape the overall systemic plan.
Less commonly, cancers of the ovary, prostate, oesophagus, and thyroid reach the brain. In a small number of patients the brain lesion is found first, before the primary cancer is known — a "metastasis of unknown origin." In these cases, imaging, biopsy, and molecular testing work together to track down the source so treatment can be precise.
This distinction shapes the entire treatment plan. A brain metastasis is treated as the same cancer that started elsewhere, while a primary brain tumour follows a different pathway. If you have a known cancer and a scan finds new brain lesions, it is almost always a metastasis — not a new primary brain tumour.
Started in the lung, breast, skin, kidney, or colon and travelled to the brain through the bloodstream. The cells match the original cancer. Treatment pairs brain-directed therapy (usually stereotactic radiosurgery) with systemic therapy chosen for the primary cancer. This is the focus of this page.
Begins in the brain itself — for example a glioma or meningioma. It is graded by the World Health Organization (WHO), not staged, and follows a different treatment pathway. Learn more in our brain tumour treatment guide.
We're never more than 30 minutes away. Same panel of specialists at every centre. Same tumour board reviews. Same NCCN protocols. Pick the closest one and call directly — or let us pick for you.
CION Ameerpet
CION Kukatpally
CION L.B. Nagar
CION Tolichowki
CION Masab Tank
CION Banjara Hills
CION Kompally
CION Balanagar
CION Siddipet
CION Sangareddy
Not sure which centre fits best? Tell us where you are — we'll suggest the closest one with the right specialists.
Help me pick the right centreTravelling for treatment? We may have a centre right where you are.
Don't see your city? Call 18002028726 — we'll find your nearest CION partner centre.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationShare your name and number — we'll call you back within 30 minutes to schedule your consultation.
Whether you have new neurological symptoms or a scan has found brain lesions, CION's tumour board can review your imaging and reports — and plan focused radiation alongside the right systemic therapy. Same-week appointments across Hyderabad.
Most brain metastases arrive through the bloodstream. Cancer cells break away from the primary tumour, enter the circulation, and lodge in the small blood vessels of the brain, where they can grow into new tumours. Because the brain has a rich blood supply and a protective barrier that behaves differently from other organs, certain cancers — lung, breast, melanoma, kidney — find it a frequent destination.
Brain metastases can appear as a single lesion or several lesions, and they most often settle where the blood flow is greatest (the junction between the brain's grey and white matter). The number, size, and location of lesions all influence which treatment is recommended.
For someone with a known cancer, certain new symptoms should prompt an urgent contrast MRI of the brain. Importantly, these symptoms have many causes — most are not brain metastases — but in a patient with advanced lung, breast, melanoma, kidney, or colon cancer they must not be ignored. The red flags are symptoms that are new, persistent, and progressive:
Important: a symptom alone does not mean cancer has spread to the brain. But early detection gives the widest range of treatment options. If you have an advanced cancer and notice these signs, speak to a CION specialist or call 18002028726.
The diagnostic pathway has two goals: confirm that the brain lesions are metastases, and identify the molecular features of the cancer that determine which drugs will work.
An MRI with gadolinium contrast is the most sensitive test for brain metastases. It shows the number, size, and location of lesions and the swelling around them — information that directly shapes whether focused radiation, surgery, or systemic therapy is recommended first.
When the source cancer is already known, the brain lesions are usually treated as metastases of that cancer. When the primary is unknown, a CT or PET scan of the body looks for the source, and a biopsy — of the brain lesion (coordinated with neurosurgical partners) or the suspected primary — confirms the origin.
This is where modern care has changed most. Testing the tumour for receptor status (such as ER, PR, HER2 in breast cancer) or driver mutations (such as EGFR, ALK, BRAF, RAS) reveals which targeted therapies and immunotherapies may help — including several newer drugs specifically able to cross into the brain. CION arranges this testing as standard so treatment is matched to your cancer, not guessed.
Treatment combines brain-directed therapy to control the lesions with systemic therapy aimed at the original cancer. The right mix depends on the number of lesions, your symptoms, the primary cancer type, and how well it is responding elsewhere. CION delivers radiation, imaging, molecular testing, and systemic therapy directly, and coordinates any neurosurgery with accredited neurosurgical partners.
For a limited number of lesions, SRS delivers highly focused radiation to each metastasis from many angles at once — without any incision, in 1 to 5 outpatient sessions. Despite the name, no cutting is involved. Modern guidelines favour SRS over whole-brain radiation for limited disease because it preserves memory and thinking. SRS at CION is delivered as part of coordinated radiosurgery and specialist care.
When there are many lesions, whole-brain radiation may still have a role. Techniques that protect the memory centre (the hippocampus) can reduce cognitive side effects. Your radiation oncologist will explain when this is the better option.
Some modern targeted therapies and immunotherapies cross into the brain and can shrink metastases from lung, breast, melanoma, and kidney cancers — sometimes alongside radiation, sometimes as the first step. Drugs are chosen by mechanism and molecular target, guided by the testing described above, and coordinated by CION's medical oncology team.
Surgical removal may be recommended for a single large lesion causing dangerous pressure, or when tissue is needed to confirm the diagnosis. CION does not perform neurosurgery in-house; we coordinate it with accredited neurosurgical partners and resume radiation and systemic care afterwards.
Steroids reduce brain swelling, and anti-seizure medicines are used when needed. Rehabilitation — physiotherapy, speech therapy, and cognitive support — helps recovery. Symptom control and quality of life are central to the plan from day one.
For patients with a limited number of brain metastases, stereotactic radiosurgery (SRS) is now generally preferred over whole-brain radiation because it controls the lesions while protecting memory and thinking. NCCN and EANO (European Association of Neuro-Oncology) guidelines both support SRS for limited brain metastases — and modern targeted drugs and immunotherapy that cross into the brain have made long-term control possible for many patients who, a decade ago, had far fewer options.
Brain metastasis is an advanced (stage 4) situation, but it does not automatically mean the cancer is untreatable. Outcomes vary widely — by the type of primary cancer, the number of lesions, your overall health, and how well the primary responds to systemic treatment.
Because the picture is so individual, there is no single survival number for brain metastases — published outcomes are reported as ranges by groups such as NCCN, EANO, and SEER, and should always be discussed in the context of your own scans and cancer type. What is clear is that modern focused radiation and newer brain-penetrating drugs have meaningfully improved control and quality of life. Some patients live well for years. The most important step is rapid, coordinated care.
A second opinion is especially valuable for brain metastases in these situations:
CION's neuro-oncology tumour board reviews imaging, pathology, and your existing plan together. Explore our brain tumour treatment options, or learn about specific sources such as lung cancer spread to the brain and breast cancer spread to the brain.
Get a free written second opinion from CION's tumour board — particularly valuable if SRS hasn't been discussed, or if molecular testing of your primary cancer hasn't been arranged.
These aren't paid endorsements or written reviews. These are video testimonials from real patients and families — recorded on their own phones, in their own words. Pick any one. Watch it. Then decide.
Read all 800+ reviews on Google
Start Your Story. Book Free Consultation.Five cancers account for the large majority of brain metastases: lung cancer (the single most common source), breast cancer, melanoma (skin cancer), kidney cancer, and colon (colorectal) cancer. Lung and breast together cause more than half of all cases. Melanoma has the highest tendency to reach the brain for its frequency. Other cancers — such as ovarian, prostate, and oesophageal — spread to the brain much less often. The pattern matters because the primary cancer guides the systemic (drug) treatment that works alongside brain-focused radiation.
A brain metastasis (secondary brain tumour) is cancer that started somewhere else — the lung, breast, skin, kidney, or colon — and travelled to the brain through the bloodstream. Under the microscope, the cells still look like the original cancer, not brain cells. A primary brain tumour, such as a glioma, begins in the brain itself. The distinction is essential: secondary tumours are treated by combining brain-directed therapy (usually focused radiation) with systemic treatment aimed at the original cancer, while primary tumours follow a different pathway. Brain metastases are several times more common than primary brain cancers.
If you already have a known cancer and a brain MRI shows new lesions, the source is usually assumed to be that cancer. When the primary is unknown — a "metastasis of unknown origin" — the team uses a contrast MRI of the brain, a CT or PET scan of the body to look for the source, and often a biopsy (of the brain lesion or the suspected primary) with molecular testing. Markers such as receptor status in breast cancer or driver mutations in lung cancer both confirm the origin and reveal which targeted or immunotherapy drugs may help. Identifying the primary is what makes precise treatment possible.
Yes. For a limited number of lesions, stereotactic radiosurgery (SRS) — highly focused radiation delivered in 1 to 5 outpatient sessions — is often the preferred option and preserves thinking and memory better than whole-brain radiation. Surgery (coordinated with accredited neurosurgical partners) may be used for a single large lesion causing pressure. Systemic therapy matters greatly: some modern targeted drugs and immunotherapies cross into the brain and shrink metastases from lung, breast, melanoma, and kidney cancers. CION delivers the radiation, imaging, molecular testing, and systemic therapy directly and coordinates any neurosurgery.
Not automatically. Brain metastasis is an advanced (stage 4) situation, but outcomes vary widely by cancer type, the number of lesions, and how well the primary cancer responds to systemic treatment. Modern focused radiation and newer brain-penetrating drugs have meaningfully improved control and quality of life for many patients — some live well for years. Outcomes are highly individual, so we avoid single survival numbers. What matters most is rapid, coordinated care: controlling the brain lesions, treating the primary cancer, and managing symptoms such as swelling and seizures. Published ranges should be discussed with your oncologist in the context of your own scans.
In someone with a known cancer, warning signs include a new or progressively worsening headache (often worse in the morning or on waking), a first-ever seizure, one-sided weakness, numbness, or clumsiness, speech difficulty, sudden vision changes, persistent nausea or vomiting, and changes in memory, behaviour, or balance. These symptoms are not proof of brain spread — many have other causes — but in a patient with advanced lung, breast, melanoma, kidney, or colon cancer they should prompt an urgent contrast MRI of the brain. Early detection gives the widest range of treatment options.
Browse our complete guide to brain tumours and brain cancer — symptoms, scans, tumour types, treatment, prognosis and life after treatment. Tap any topic to read more.